SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs quarterly earnings report is the focal point, with traders watching guidance, subscriber engagement, advertising growth, and content strategy amid leadership changes and layoffs. Bearish concerns about competition, content quality, and slowing growth contrast with bullish hopes that low expectations and ad expansion could support a positive reaction.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally is drawing attention as traders position around the full Phase 3 melanoma cancer-vaccine data presentation at ESMO, following previously reported positive topline results. Bulls see the readout as validation of the oncology pipeline, while skeptics warn that expectations and valuation are elevated and debate whether the event could prompt profit-taking.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

SRPTs sharp rebound is drawing attention, with traders attributing the move to possible short covering and technical buying rather than a confirmed new company announcement. The broader debate centers on upcoming DM1 and FSHD siRNA data: Novartis/Aviditys DM1 trial failure raised concerns about whether target knockdown can translate into patient benefit, while some traders argue Sareptas distinct delivery approach and the loss of a competitor could be favorable.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Sea shares are falling amid concern over plans to list its Monee financial-services arm and launch Sea Cloud, which traders worry could add spending and strategic uncertainty. The community is split between viewing a Monee separation as a potential value unlock and fearing it could weaken the remaining business, while some see the selloff as an overreaction.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GM is selling off despite a third-quarter earnings beat and a new buyback authorization, as traders focus on narrowed full-year profit guidance with an unchanged midpoint and weaker vehicle sales. Some view the drop as overdone given the stronger cash-flow outlook and buyback, while others see the outlook as too cautious to offset the earnings-day disappointment.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GE Aerospaces earnings beat and raised outlook drew attention as shares sold off despite strong demand, with traders frustrated by the reaction. The debate centers on whether higher costs, weaker cash generation and an insurance loss outweigh the stronger orders and guidance.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Attention is centered on TG Therapeutics MSToronto presentations, especially initial Phase 1 azer-cel results in progressive MS, alongside new BRIUMVI data. Traders are hopeful azer-cel could add a growth opportunity beyond BRIUMVI, while recognizing the early readouts efficacy is uncertain; continued BRIUMVI sales growth is the more established part of the story.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizers push to a fresh 52-week high is drawing attention, with traders celebrating a long-awaited recovery and debating whether the breakout can hold or will meet resistance. Some point to defensive-sector demand and pipeline progress, while others say the move needs a clearer company-specific catalyst.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

Rapports Phase 2 RAP-219 trial in bipolar mania met its primary and secondary endpoints, driving attention to the drugs potential and analyst optimism. Traders are debating whether the placebo-adjusted benefit is modest and whether agitation concerns and higher discontinuations could limit the upside, with some viewing the move as vulnerable to a fade.

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Myriad Genetics, Inc.

Myriad Genetics agreement to sell its prenatal testing business to Labcorp is driving a sharp rally, with traders viewing the cash proceeds as a balance-sheet and strategic boost. Others question the deal because the divested unit contributes revenue, raising concerns about debt and the outlook for the remaining business; some traders are also taking profits after the surge.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Palantir Stock Rises After-Hours: It’s Reportedly Building Software For Trump’s $185B Golden Dome Missile Shield

Equity

The AI data analytics firm, alongside other tech players, is developing software expected to underpin the government’s Golden Dome missile defense system, the Wall Street Journal reported.


Palantir shares edges up on expanded government role, amid privacy concerns

Investing.com -- Shares of  Palantir Technologies Inc  . (NYSE:NASDAQ:PLTR) rose 0.8% pre-open following a  New York Times  (NYSE:NYT) report detailing the company’s increasing involvement with the Trump administration’s data-sharing initiatives. The report revealed that Palantir has been selected to play a central role in President Trump’s executive order to enhance inter-agency data sharing, a move that could potentially consolidate the President’s surveillance capabilities.

Themes ETF Trust - Leverage Shares 2X Long PLTR Daily ETF

Bearish Sentiment

<ul class="summary-bullets"><li>PLTR stock rose 1.2% in Tuesday’s after-hours session.</li><li>Shares have climbed sharply as the U.S.-Iran war enters its third week; Observers speculate on the use of Palantir’s tech in U.S. operations in Iran.</li><li>Palantir is among the companies investors are closely tracking as U.S. military activity has intensified in recent months.</li></ul>Palantir Technologies is among a group of tech companies that are developing software to run President Trump’s planned Golden Dome antimissile shield, the Wall Street Journal reported on Tuesday, citing people familiar with the matter.Palantir shares rose 1.2% in the after-hours session, following the report. Stocks rose broadly in the evening on&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/world/asia-pacific/iran-sends-waves-missiles-into-israel-dismisses-trumps-talk-negotiations-fake-2026-03-24/">reports</a> that the U.S. was seeking a month-long ceasefire in its war on Iran and had sent a 15-point plan to Iran for discussion, raising hopes that the war would end and that oil exports from the ​Persian Gulf would resume.<h2 class="st-heading-2">PLTR Partners For Golden Dome Software</h2>Defence tech startup Anduril Industries, Aalyria Technologies, which develops software and laser-based communications systems, Meta Platforms-backed Scale AI, and operating systems firm Swoop Technologies are part of the group, according to the Journal’s&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.wsj.com/politics/national-security/anduril-palantir-are-developing-golden-dome-missile-shields-software-63c36db4">report</a>.If the software proves itself in the live demonstration, it could serve as a foundational element of the $185 billion defense system, opening the door for its developers to capture a highly lucrative, multi-billion-dollar opportunity in building and sustaining the platform over time.The Golden Dome is a proposed missile-defense system that combines space-based sensors and interceptors with ground-based radars and missiles to shield land-based assets and life from aerial attacks. It was announced by President Donald Trump in May 2025.<h2 class="st-heading-2">Defence Play A Major Draw</h2>Past reports speculating involvement of firms like&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/fly-stock-lights-up-retail-radar-on-golden-dome-buzz-alpha-rocket-upgrade/cmUlh5FR4JF">Firefly Aerospace</a> and&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/asts-stock-eyes-third-straight-weekly-gain-on-golden-dome-defense-buzz/cmUlVDeR4JC">AST SpaceMobile</a> in the Golden Dome project have sparked rallies in their stocks. In October, the Journal reported that SpaceX was&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/spacex-set-to-bag-2b-government-funding-to-develop-golden-dome-satellites-report/cLGpxCkR3UL">set to receive</a> a $2 billion contract under the initiative to develop satellites that can track missiles and aircraft, although there has been no news on the potential deal since.Palantir, which has emerged as a key software and AI vendor to the defense sector, is among the companies investors are closely tracking as U.S. military activity has intensified in recent months – culminating in the ongoing Iran conflict, now roughly a month in, where its technology is reportedly being used in battlefield targeting and planning.&nbsp; ￼Palantir’s Maven AI system will&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/technology/pentagon-adopt-palantir-ai-as-core-us-military-system-memo-says-2026-03-20/">become an official program of record</a>, Deputy Secretary of Defense Steve ​Feinberg said in a letter to Pentagon leaders earlier this month, a move that locks in long-term use of Palantir’s weapons-targeting technology across ‌the U.S. military.<h2 class="st-heading-2">Retail’s View On PLTR</h2>On Stocktwits,&nbsp;retail sentiment for PLTR dropped to ‘bearish’ from ‘neutral’ the previous day amid lingering geopolitical uncertainty, but a flurry of upbeat commentary has begun to emerge.<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_03_25_at_7_15_40_AM_png_cb634eb721.webp" alt="Screenshot 2026-03-25 at 7.15.40 AM.png" width="659" height="86"><figcaption>PLTR sentiment and message volume as of March 24 | Source: Stocktwits</figcaption></figure>“If you’re not investing in this , then I hate to be mean but you have mush brains,”&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.stocktwits.com/Mogh/message/648462231">posted</a> one bullish user.<stembedurl>https://stocktwits.com/Mogh/message/648462231</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/bsome191/message/648464353">speculated</a> PLTR’s stock to hit $200 next week, implying a 27% jump from current levels.<stembedurl>https://stocktwits.com/bsome191/message/648464353</stembedurl><a href="https://stocktwits.com/symbol/PLTR">Palantir shares</a> have risen by over 20% from their 2026 low on Feb. 13; however, they are still down 13% year-to-date.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

An illustration photo shows Palantir logo in a smartphone. (Photo credit should read CFOTO/Future Publishing via Getty Images)

The AI data analytics firm, alongside other tech players, is developing software expected to underpin the government’s Golden Dome missile defense system, the Wall Street Journal reported.

PLTR Stock Jumps After-Hours On Report Of Potential Play In Trump's Golden Dome

AST SpaceMobile Inc

Firefly Aerospace Inc.

Leverage Shares 2X Long PLTR Daily ETF

Palantir Technologies Inc

GraniteShares 2x Long PLTR Daily ETF

Double beat (rev + EPS)

Revenue beat, EPS miss

EPS beat, revenue miss

Double miss

SpaceX ($SPCX) reports earnings after the close today. What do you expect?

Stocktwits

SpaceX

) reports earnings after the close today. What do you expect?

Current Price	$21.20
Prev Close	$20.92
Open	$19.95
Dividend Yield	N/A
50-Day Moving Average	$19.36
Beta	N/A
Avg. Volume	94,834.63
PE Ratio	N/A

52-Week High	$44.95
52-Week Low	$7.54
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

PLTG Fundamentals